BSX vs HHS · P/E 20, rev $10.65B vs rev $75.2M
Boston Scientific Corp (BSX) versus Harte Hanks Inc (HHS) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Harte Hanks Inc (HHS) is a conglomerates company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported HHS revenue for 2026-06-30 was $75.2M. Net income was -$5.6M. HHS currently screens at market cap $27.7M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. HHS currently screens at market cap $27.7M.
Not investment advice. Open the BSX and HHS stock pages for the full models.
Not investment advice.